Skip to main content
. 2012 Sep;30(3):257–261. doi: 10.3329/jhpn.v30i3.12288

Table.

Proportions of STEC infections in HUS case-control studies

HUS cases Controls
Author Year Country Duration of study Study population with HUS Positive for STEC (%) Population Positive for STEC (%)
Cordovéz* (14) 1992 Chile 1988-1989 20 6 (30.0) 38 2 (5.3)
Gianviti (15) 1994 Italy 1988-1992 68 49 (72.0) 58 2 (3.0)
Greatorex (16) 1994 USA 1989-1992 27 23 (85.2) 47 3 (6.4)
Jure (17) 1998 Argentina 1994-1996 19 12 (63.2) 17 0
Karmali (18) 1985 Canada 1980-1983 40 24 (60.0) 40 0
Kishore (19) 1992 India NA 28 19 (67.9) 25 0
Kleanthous* (20) 1990 United Kingdom 1985-1988 185 58 (31.3) 148 9 (6.1)
Lopez (21) 1989 Argentina 1986-1988 51 34 (66.7) 64 13 (20.3)
Total 438 437
Median (IQR) 64.95 (52.8-68.9) 4.15 (0-6.175)

*No serology tests;

HUS=Haemolytic-uraemic

syndrome;

IQR=Interquartile range;

NA=Not applicable;

STEC=Shiga toxin-producing Escherichia coli